← Leaderboards
Priyathama Vellanki
Emory University
$880,777
Attributed
$880,777
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $264.4K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$880,777 · 2
By mechanism
K23$646,027 · 1
R03$234,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Lawrence S Phillips$7,132,519
- Dawn Diese Smiley$594,000
- Janet D Klein$1,660,745
- Inyeong Choi$2,700,232
- Kabayam M Venkat Narayan$7,626,484
Others in their field
Other Emerging Leaders on “Maintenance”
- Leonard Freedman · Leidos Biomedical Research, Inc.$116,229,352
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$70,940,087
- Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
- Scott Dahm · Association Of Universities For Research In Astronomy, Inc.$39,961,632
- Robert D Blum · Association Of Universities For Research In Astronomy, Inc.$30,497,056
Research focus
MaintenanceLeadImmunologicsInsulinInsulin SecretionIn VivoExhibitsHyperglycemiaInsightImpairmentInsulin-Dependent Diabetes MellitusInsulin ResistanceDiabetes MellitusInsulin SensitivityAffectDisease RemissionFollow-UpGlycosylated Hemoglobin ACell PhysiologyAfrican AmericanBeta CellDefectDiabetic KetoacidosisMetabolic
Grant awards (6)
Mechanisms of ketosis and near-normoglycemia remission in obese African Americans with ketosis-prone diabetes$117,375
R03 · FY2023 · DK · contact PI
Mechanisms of ketosis and near-normoglycemia remission in obese African Americans with ketosis-prone diabetes$117,375
R03 · FY2022 · DK · contact PI
Epigenetic Markers of Short- and Long- Term Near-Normoglycemia Remission in Patients with Ketosis-Prone Diabetes$190,080
K23 · FY2021 · DK · contact PI
Epigenetic Markers of Short- and Long- Term Near-Normoglycemia Remission in Patients with Ketosis-Prone Diabetes$74,287
K23 · FY2021 · DK · contact PI
Epigenetic Markers of Short- and Long- Term Near-Normoglycemia Remission in Patients with Ketosis-Prone Diabetes$190,080
K23 · FY2020 · DK · contact PI
Epigenetic Markers of Short- and Long- Term Near-Normoglycemia Remission in Patients with Ketosis-Prone Diabetes$191,580
K23 · FY2019 · DK · contact PI